IL2 and hereditary clear cell renal cell carcinoma: Although, treatment of renal cell carcinoma patients with an IL-2 encoding plasmid led to a low number of responses (163, 164), injection of recombinant IL-2 into melanoma metastases induced high response rates resulting in tumor regression.